Stock tip: ILMN

Tags:stocks

http://finance.google.com/finance?client=ob&q=ILMN
With no clear competitors (454 is the “old” standard in sequencing and is quickly being replaced, and ABI just sucks), and a $500,000 Genome Analyzer platform that’s selling dozens to huge labs across the country, Illumina is posed to explode. Having bought Solexa last yaer, their stock has doubled in the past year, and it’s going to keep going up for the next few years. Unlike most technology, the GA isn’t going to be replaced by the next great thing — from Illumina or someone else — since the GA is incredibly upgradeable and scalable. This probably won’t take us all the way to the $10K genome, but it’s going to be used so much in research worldwide that it’s worth buying and holding!!

Buy now

PS I have no competing interest here, and I’m sharing just because I don’t have a stock portfolio :(

Comments